QGEN
What one share of Qiagen holds
Biological Products, (No Diagnostic Substances)
QIAGEN provides sample and assay technologies that enable customers to extract, detect and interpret molecular information from biological samples.
Qiagen’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Sales | $9.55 |
|---|---|
| Profit | $1.94 |
| Capex (buildings and equipment) | $0.92 |
| Free cash flow | $2.07 |
| Dividends | $0.25 |
| Cash and investments | $3.87 |
| Debt | $7.63 |
| Book value | $17.42 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2008 | $4.37 | $0.44 | $0.19 | $0.65 | — | $7.39 |
| 2009 | $4.73 | $0.64 | $0.24 | $0.77 | — | $9.87 |
| 2010 | $4.52 | $0.60 | $0.33 | $0.71 | — | $10.62 |
| 2011 | $4.89 | $0.40 | $0.36 | $0.66 | — | $10.88 |
| 2012 | $5.21 | $0.54 | $0.42 | $0.59 | — | $11.48 |
| 2013 | $5.38 | $0.29 | $0.35 | $0.72 | — | $11.61 |
| 2014 | $5.54 | $0.48 | $0.36 | $0.83 | — | $11.42 |
| 2015 | $5.37 | $0.55 | $0.41 | $0.92 | — | $11.01 |
| 2016 | $5.60 | $0.34 | $0.31 | $1.12 | — | $11.11 |
| 2017 | $6.08 | $0.17 | $0.39 | $0.84 | — | $11.22 |
| 2018 | $6.43 | $0.82 | $0.47 | $1.07 | — | $11.68 |
| 2019 | $6.73 | −$0.18 | $0.52 | $0.94 | — | $11.14 |
| 2020 | $7.99 | $1.53 | $0.57 | $1.39 | — | $12.27 |
| 2021 | $9.70 | $2.21 | $0.82 | $1.94 | — | $13.64 |
| 2022 | $9.31 | $1.84 | $0.56 | $2.55 | — | $15.22 |
| 2023 | $8.52 | $1.48 | $0.65 | $1.34 | — | $16.69 |
| 2024 | $8.80 | $0.37 | $0.74 | $2.25 | — | $16.05 |
| 2025 | $9.55 | $1.94 | $0.92 | $2.07 | $0.25 | $17.42 |